Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors.
Martins D, Spada F, Lambrescu I, Rubino M, Cella C, Gibelli B, Grana C, Ribero D, Bertani E, Ravizza D, Bonomo G, Funicelli L, Pisa E, Zerini D, Fazio N; IEO ENETS Center of Excellence for GEP NETs.
Martins D, et al.
Target Oncol. 2017 Oct;12(5):611-622. doi: 10.1007/s11523-017-0506-5.
Target Oncol. 2017.
PMID: 28634872
Review.